• 제목/요약/키워드: Partial Response(Remission)

검색결과 61건 처리시간 0.04초

전폐 세척술로 부분 관해 후 GM-CSF 투여로 치료된 특발성 폐포단백증 1예 (A Case of Idiopathic Pulmonary Alveolar Proteinosis Treated with Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) after Partial Response to Whole Lung Lavage)

  • 송준휘;박순효;강경우
    • Tuberculosis and Respiratory Diseases
    • /
    • 제67권6호
    • /
    • pp.569-573
    • /
    • 2009
  • Idiopathic pulmonary alveolar proteinosis (PAP) is a rare disorder characterized by surfactant component accumulation in the alveolar space. Idiopathic PAP has recently been recognized as a autoimmune disease of impaired alveolar macrophage function caused by autoantibodies against granulocyte-macrophage colony-stimulating factor (GM-CSF). While whole lung lavage has been the standard treatment, not every patient shows a complete response. Subcutaneous injection or inhalation of GM-CSF is another promising treatment option for PAP. A 45-year-old patient visited our hospital for dyspnea, he was diagnosed as PAP and underwent whole lung lavage. Eighteen months later, the patient had not achieved complete remission in despite of initial response. After then he was administered with GM-CSF (5 ${mu}g/kg/day$, subcutaneous injection) for fivetimes a week during 2 months. Nine months later, the abnormal shadows in high-resolution computed tomography (HRCT) decreased and the patient fully recovered in forced vital capacity. After 60 months, the HRCT scan showed complete remission of PAP.

식도암의 방사선치료 성적 (The Result of Radiotherapy in Esophageal Cancer)

  • 박찬일;최은경;정웅기;방영주;김노경
    • Radiation Oncology Journal
    • /
    • 제6권2호
    • /
    • pp.227-233
    • /
    • 1988
  • 1979년 3월부터 1986년 8월까지 식도의 편평상피암으로 진단되어 서울대학교병원 치료방사선과에서 방사선치료를 받은 177명중 근치적 방사선 치료를 시행한 152명을 대상으로 후향성 분석을 시행하여 다음과 같은 결과를 얻었다. $80\%$이상의 환자에서 관해를 보였으며, 이중 완전관해는 $22\%$, 부분 관해는 $63\%$이었다. 전체 환자의 2년, 5년 생존율은 각각 $22.9\%,\; 13.3\%$이었으며 식도암의 위치, 크기, 병기 그리고 관해 정도에 따라 생존율에 차이가 있었다. 식도 촬영상 5cm 이하$(17\%)$ 또는 식도의 상부 1/3에 종양이 있는 경우$(25.6\%)$에 가장 좋은 5년 생존율을 보였다. 관해 정도에 따른 생존율은 완전관해를 보인 경우의 5년 생존율이 $34.3\%$인 반면 반응이 없던 경우는 $0\%$이었다

  • PDF

전신병기(Extensive stage) 소세포 폐암 환자에서 항암 화학요법 성적 : VPP/CAV 및 Carboplatin/Etoposide(CE) 복합 화학요법의 치료효과 (Effect Of VPP/CAV Alternating Chemotherapy Versus Carboplatin/Etoposide(CE) Chemotherapy For Extensive Stage Small Cell Lung Cancer)

  • 김선영;서재철;김명훈;박희선;강동원;이규승;고동석;김근화;정성수;김주옥
    • Tuberculosis and Respiratory Diseases
    • /
    • 제48권5호
    • /
    • pp.740-747
    • /
    • 2000
  • 연구배경 : 저자들은 전신병기 소세포 폐암 환자중 VPP/CAV 교대요법을 받은 환자군과 CE요법을 받은 환자군에 대하여 치료반응과 생존기간 그리고 부작용 등을 평가 하여 전신 병기 소세포 폐암 환자의 초치료로 CE요법이 유용한가에 대하여 알아보고자 하였다. 방법 : VPP/CAV교대요법을 받은 환자들은 cisplatin 60mg/$m^2$를 제 1일에 정주하였고 etoposide 100mg/$m^2$를 제 1일에서 제 3일까지 정주한 후, 3주 후에 다시 cyclophosphamide 1000mg/$m^2$, adriamycin 40mg/$m^2$, vincristine 1.4mg/$m^2$를 정주하였고 매 3주마다 반복하였다. CE요법을 받은 환자들은 carboplatin 325mg/$m^2$를 제 1일에 정주하였고, etoposide 100mg/$m^2$를 제 1일에서 제 3일까지 정주하여 매 3주마다 반복하였다. 양군 모두에서 필요한 경우에는 고식척인 방사선 시행하였다. 결과 : 전체 반응률은 61.4% 이었고 중앙 생존기간은 10.8개월이었다. VPP/CAV교대요법군의 경우 반응률은 54.5%, 중앙 생존기간은 9.5개월이었고, CE요법군의 경우 반응률은 68.2%, 중앙 생존기간은 11개월이었으나 양군간에 통계학적인 차이는 없었으며 부작용은 비슷하였으나, CE요법 군에서 빈혈이 더 많았다. 결론 : CE요법은 VPP/CAV교대요법과 동등한 반응률을 보였으며 부작용도 수용할만하여 전신병기 소세포 폐암환자들에서 초치료 약제로 적절한 것으로 판단된다.

  • PDF

Clofarabine in the Treatment of Elderly Patients with Acute Myeloid Leukemia

  • Aleem, Aamer;Anjum, Farhan;Algahtani, Farjah;Iqbal, Zafar;Alsaleh, Khalid;AlMomen, Abdulkareem
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제14권2호
    • /
    • pp.1089-1092
    • /
    • 2013
  • Background: Elderly patients with acute myeloid leukemia (AML) have a poor outcome because of co-morbidities, poor tolerance to intensive chemotherapy and inherently more resistant disease. Clofarabine is a second generation nucleoside analogue which has shown promising activity in elderly patients with AML. This study was conducted to review the outcome of treatment with clofarabine in a group of such patients. Methods: The records of 5 elderly patients who were diagnosed to have AML and treated with clofarabine over a 12 month period were reviewed retrospectively. Results: There were 2 female and 3 male patients with a median age of 68 years (range 65-82). At the time of treatment, 2 patients had newly diagnosed AML not considered suitable for intensive therapy, while 3 patients had partial or no response to conventional chemotherapy. The overall response rate was 100%, all patients achieving a complete remission. Induction and consolidation were well tolerated. All patients developed neutropenia with a median duration of 20 days (range 17-42). One patient developed hand and foot syndrome and a generalized rash but recovered. There was no mortality and all patients remained in remission after a median follow-up of 5.2 months (Range 3-10). Conclusion: Clofarabine (alone or in combination) is active in elderly AML patients with an acceptable safety profile and should be considered a potential option in this group.

소아 특발성 신증후군에 관한 고찰 (Clinical Review of Idiopathic Nephrotic Syndrome in Children)

  • 심현섭;추정민;이대열
    • Childhood Kidney Diseases
    • /
    • 제6권1호
    • /
    • pp.37-47
    • /
    • 2002
  • 목 적 : 신증후군의 발생빈도, 임상양상, 스테로이드와 면역억제제에 대한 반응 및 조직학적 소견을 관찰하고자 한다. 대상 및 방법 : 22년간 전북대학교별원 소아과에 특발성 신증후군으로 입원했던 환자 185명 중 4개월 이상 관찰이 가능했던 159명을 대상으로 입원당시 병력, 임상증상, 검사소견, steroid에 대한 반응, 재발빈도 및 추적 기간을 관찰하였으며 재발이 빈번하거나 steroid 요법에 반응이 좋지 않았던 72례에서의 약물의 효과와 신생검을 실시한 76례에서 조직학적 소견을 관찰하였다. 결 과 : 연도별로 매년 3례에서 17례 입원하였으며 연도별 큰 차이는 없었고 남녀비는 4:1로 남아에서 많았다. 연령별 분포는 3-5세 사이가 34례($21.4\%$)로 가장 많았으며 계절별로는 겨울에 입원한 환아가 46례로 많았다. 발병에서 입원까지 기간은 발병 3개월 이내에 내원한 환아가 107례($68.2\%$)로 가장 많았으며 입원당시 주증상으로는 전신부종($75.5\%$), 복수($28.3\%$), 고환 부종($20.1\%$), 상기도 감염($19.5\%$), 핍뇨($15.1\%$) 등 이었다. Steroid 요법후 2주 이내에 대부분에서 이뇨가 일어났으며 단백뇨는 첫 2주 이내에 $66\%$에서 소실되었다. Steroid 요법에 대한 반응는 완전관해 110례($69\%$), 부분관해 29례($18\%$), 무반응 20례($13\%$)이였다. 혈뇨, 고혈압, 혈청 creatinine상승 등의 신염 소건은 각각 $32\%,\;23.9\%,\;10.7\%$ 였으며 steroid 요법에 반응이 없는 군에서 높았다. 초기 steroid 요법에 반응이 좋았던 환아에서 1년 이상 추적 관찰이 가능했던 78례 중 1년 이내에 재발한 경우는 55례($75\%$)이였다. Steroid 요법에 반응이 없거나 재발이 빈번한 환아에서 면역억제제를 투여하였으며 cyrlopho- sphamide를 투여한 62례 중 38례에서 어느 정도 효과가 있었으며 cyclosporine의 경우 7례 중 6례에서 효과가 있었다. Steroid 요법에 반응이 없거나 재발이 빈번한 76례에서 신생검을 실시하였으며 미세변화형이 53례($69.7\%$)로 가장 많았다.

  • PDF

후두 접촉성 육아종의 수술적 치료 (Surgical treatment of laryngeal contact granuloma)

  • 유병준;타오정;이동원;송창면;지용배;태경
    • 대한두경부종양학회지
    • /
    • 제33권2호
    • /
    • pp.23-27
    • /
    • 2017
  • Background and Objectives: Gastric acid reflux is known to be the most important cause of contact granuloma. Therefore, anti-gastric acid reflux medication has been used as the first line treatment although there are other treatment methods such as surgery or steroid injections. Actually, the role of surgery in the treatment of contact granuloma has not been established clearly. The purpose of this study was to evaluate the effectiveness of surgical treatment for contact granuloma. Materials and Methods: We retrospectively reviewed the medical records of 14 patients who were diagnosed with contact granuloma and treated with surgery from 2011 to July 2016 at Hanyang University hospital. Results: Of 14 patients, 9 (64.3%) were male and 5 (27.4%) were female. The mean age was 53.8 (${\pm}6.1$) years. The main symptoms were voice change followed by globus, dyspnea, and asymptomatic. Mean Reflux Finding Score (RFS) before surgery was 13.5 and mead Reflux Symptom Index (RSI) was 10.4. The causes of surgery were inadequate response to proton pump inhibitor (PPI) in 4 cases, airway obstruction with large granuloma in 8 cases, and differential diagnosis in 2 cases. Of 14 patients, recurrence occurred in 8 (53.3%) patients after surgery. In 8 recurrent cases, 5 patients showed complete remission and 3 patients showed partial remission with PPI medication. Conclusion: The role of surgery in the treatment of contact granuloma might be limited due to high recurrence rate.

제한병기 소세포폐암 환자의 치험례 임상보고 (A Clinical Report of the Patient with Limited-Stage Small Cell Lung Cancer)

  • 박정섭;이시형;임영남;정기용;전찬용;박종형;김동우
    • 대한한방내과학회지
    • /
    • 제26권3호
    • /
    • pp.677-684
    • /
    • 2005
  • Objectives : This study was designed to evaluate the effects of oriental herb medicine therapy on a limited stage small ell lung cancer(SCLS) patient. Methods : The medical record of this case of SCLS was researched. The patient had been treated with oriental herb medicine for five months continuously in OPD. Clinical data was analyzed and the mass of small cell lung cancer before and after oriental herb medicine therapy was compared using X-ray and CT scan of the whole body in order to determine metastasis. Result : After 5 months of oriental herb medical treatment, most of symptoms disappeared or improved. The small cell lung cancer patially receeded and improvements were mainly seen in sputum, coughing, insomnia, diarrhea, and performance status. Conclusion : The study suggests that oriental herb medicine therapy effects the tumor size by causing remission and Improving health and relieving symptoms, and also positively effects the quality of life as a supportive or curative therapy for SCLC patients.

  • PDF

Intensity-modulated Radiotherapy Combined with Endocrine Therapy for Intermediate and Advanced Prostate Cancer: Long-term Outcome of Chinese Patients

  • Luo, Hua-Chun;Cheng, Hui-Hua;Lin, Gui-Shan;Fu, Zhi-Chao;Li, Dong-Shi
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제14권8호
    • /
    • pp.4711-4715
    • /
    • 2013
  • Aim: The aim of this study was to evaluate acute adverse events and efficacy of three-dimensional intensitymodulated radiotherapy (IMRT) combined with endocrine therapy for intermediate and advanced prostate cancer. Methods: Sixty-seven patients were treated with three-dimensional IMRT combined with maximum androgen blockade. The correlation between radiation-induced rectal injury and clinical factors was further analyzed. Results: After treatment, 21 patients had complete remission (CR), 37 had partial remission (PR), and nine had stable disease (SD), with an overall response rate of 86.5%. The follow-up period ranged from 12.5 to 99.6 months. Thirty-nine patients had a follow-up time of ${\geq}$ five years. In this group, three-year and five-year overall survival rates were 89% and 89.5%, respectively; three-year and five-year progression-free survival rates were 72% and 63%. In univariate analyses, gross tumor volume was found to be prognostic for survival ($X^2$ = 5.70, P = 0.037). Rates of leucopenia and anemia were 91.1% and 89.5%, respectively. Two patients developed acute liver injury, and a majority of patients developed acute radiation proctitis and cystitis, mainly grade 1/2. Tumor volume before treatment was the only prognostic factor influencing the severity of acute radiation proctitis (P < 0.05). Conclusions: IMRT combined with endocrine therapy demonstrated promising efficacy and was well tolerated in patients with intermediate and advanced prostate cancer.

Micronucleus Expression and Acute Leukemia Prognosis

  • Wang, Run-Chao;Yang, Lei;Tang, Yang;Bai, Ou
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제14권9호
    • /
    • pp.5257-5261
    • /
    • 2013
  • The micronucleus frequency (MNF) in peripheral blood lymphocytes (PBL) is a biomarker of chromosomal damage and genome instability in human populations.The relationship of micronucleus frequency with prognosis of patients with acute leukemia is not clear. We therefore investigated MNF in mitogen-activated peripheral blood lymphocytes from patients with hematologic diseases and solid tumours. Patients included 50 with acute leukemia, 49 diagnosed with myelodysplastic syndrome (MDS), 54 with benign blood diseases, and 45 with solid tumours, examined with 50 healthy controls. The mean MNF was significantly higher in cases of hematologic diseases and solid tumor patients than in healthy controls (P<0.001). There was no evident difference between MNF in the acute leukemia ($7.15{\pm}2.18$) and solid tumor groups ($7.11{\pm}1.47$), but both were higher than in the MDS group ($5.12{\pm}1.29$) and benign blood diseases group ($3.08{\pm}1.08$). Taking 7.15‰, the average MNF of the acute leukemia group as standard, and dividing 50 cases of acute leukemia patients into high MNF group ($MNF{\geq}7.15$‰) and low MNF group (MNF<7.15‰). The overall response (complete remission + partial remission) rates of the low MNF group were significantly higher than in the high MNF group (P=0.001). The high MNF group further showed lower overall survival rates than the low MNF group. MNF expression and progression-free survival seemed to have a opposite relationship, with a correlation coefficient of -0.702. These data indicate that MNF in peripheral blood lymphocytes is important for evaluation of prognosis of acute leukemia patients, and it can reflect progression of disease to a certain degree.

전이성 분화 갑상선암에서 200mCi 방사성 옥소 치료효과 평가를 위한 혈청 Thyroglobulin 추적검사와 전신스캔의 의의 (Evaluation of Therapeutic Effect with Serum Thyroglobulin and Whole Body Scan after 200mCi $^{131}I$ Treatment in Patients with Well-Differentiated Thyroid Carcinoma)

  • 이창희;윤종길;정상훈;권교선;최창운;임상무;홍성운
    • 대한핵의학회지
    • /
    • 제29권4호
    • /
    • pp.451-459
    • /
    • 1995
  • Thirty-eight patients with metastatic well-differentiated thyroid carcinoma treated with 200mCi $^{131}I$ were studied. There were false negative serum thyroglobulin values during TSH suppression or at anti-thyroglobulin antibody(+) and discrepancies between findings of whole body scan and serum thyroglobulin level. After one to five cycles of 200mCi $^{131}I$ therapy, complete remission and partial remission were achieved at 5.3% and 57.9%, respectively. We concluded that all of serum thyroglobulin, TSH, anti-thyroglobulin antibody, $^{131}I$ or $^{123}I$ whole body scan were necessary in follow up of metastatic well-differentiated thyroid carcinoma. Also, if there was no response after repetitive 200mCi $^{131}I$ therapy, higher doses of $^{131}I$ therapy should be considered.

  • PDF